Drug Metabolite
Drug metabolite results when a drug is metabolized into a modified form which continues to produce effects. Drug metabolism redox reactions such as heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations can yield active metabolites, and in rare cases even conjugation reactions can yield an active metabolite.
Products Related to Drug Metabolite(571)
- GC39443Solriamfetol hydrochlorideCAS: 178429-65-7Purity: >99.00%
Solriamfetol hydrochloride은 도파민과 노르에피네프린 재흡수 억제제이다. Solriamfetol hydrochloride은 시냅스 전 신경세포에 의해 도파민과 노르에피네프린의 재흡수를 차단한다. Solriamfetol hydrochloride은 발작성 수면증이나 수면 무호흡증과 관련된 주간 졸음을 치료하는데 사용된다.
- GC396113'-Hydroxy RepaglinideCAS: 874908-14-2Purity: >98.00%
3'-Hydroxy Repaglinide는 Repaglinide의 주요 CYP2C8 대사 산물입니다.
- GC39757Etilevodopa hydrochlorideCAS: 39740-30-2Purity: >98.50%
레보도파의 에틸 에스테르 전구약물인 에틸레보도파(L-도파 에틸 에스테르) 염산염은 위장관에서 비특이적 에스테라제에 의해 레보도파와 에탄올로 빠르게 가수분해됩니다.
- GC398413,4-Dehydro CilostazolCAS: 73963-62-9Purity: >98.00%
3,4-Dehydro Cilostazol(OPC-13015)은 Cilostazol의 활성 대사 산물입니다.
- GC40018Donepezil N-oxideCAS: 120013-84-5Purity: >98.00%
Donepezil N-oxide is an active metabolite of the acetylcholinesterase inhibitor donepezil.
- GC40099Leukotriene D4 MaxSpec® StandardCAS: 73836-78-9Purity: >97.00%
류코트리엔 D4 MaxSpec® 표준은 강력한 기관지 수축제입니다.
- GC40143DihydrotetrabenazineCAS: 3466-75-9Purity: >98.00%
Dihydrotetrabenazine is an active metabolite of the vesicular monoamine transporter 2 (VMAT2) inhibitor tetrabenazine that is generated by hepatic carbonyl reductases.
- GC40145(S)-LaudanosineCAS: 2688-77-9Purity: >98.00%
(S)-Laudanosine is the (S) enantiomer of laudanosine, a metabolite of the neuromuscular blocking agents atracurium and cisatracurium.
- GC40190Febuxostat Acyl GlucuronideCAS: 1351692-92-6Purity: >98.00%
Febuxostat acyl glucuronide is a metabolite of the xanthine oxidoreductase inhibitor febuxostat.
- GC40191Ibuprofen Carboxylic AcidCAS: 15935-54-3Purity: >98.00%
Ibuprofen carboxylic acid is a major metabolite of ibuprofen.
- GC40286(E,Z)-2-propyl-2-Pentenoic AcidCAS: 60218-41-9Purity: >98.00%
(E,Z)-2-propyl-2-Pentenoic acid is a bioactive metabolite of valproic acid that exhibits the same profile and potency of anticonvulsant activity in animal models as its parent compound without any observed teratogenicity and hepatotoxicity.
- GC40298N-acetyl-5-Aminosalicylic AcidCAS: 51-59-2Purity: >98.00%
N-acetyl-5-Aminosalicylic acid is a metabolite of the anti-inflammatory agent 5-aminosalicylic acid and its prodrug form, sulfasalazine.
- GC40300DihydroresveratrolCAS: 58436-28-5Purity: >98.00%
Dihydroresveratrol is a major metabolite of resveratrol that is produced by animal-associated bacteria, including the gut microbiota.
- GC40301Tamoxifen N-oxideCAS: 75504-34-6Purity: >98.00%
Tamoxifen is a selective estrogen receptor modulator that evokes tissue-dependent effects.
- GC40480α-Phenyl-α-(2-pyridyl)acetonitrileCAS: 5005-36-7Purity: >98.00%
α-Phenyl-α-(2-pyridyl)thioacetamide, also known as antigastrin and SC-15396, is an inhibitor of gastric acid secretion.
- GC405297-hydroxy WarfarinCAS: 17834-03-6Purity: >98.00%
7-hydroxy Warfarin is a metabolite of (-)-warfarin, which is a more potent vitamin K antagonist than (+)-warfarin.
- GC40616Des-4-fluorobenzyl MosaprideCAS: 152013-26-8Purity: >96.00%
Des-4-fluorobenzyl Mosapride is the primary metabolite of mosapride.
- GC406752-deoxy-ArtemisininCAS: 72826-63-2Purity: >98.00%
2-deoxy-Artemisinin is an inactive metabolite of the antimalarial agent artemisinin.
- GC40834cis-EntacaponeCAS: 145195-63-7Purity: >98.00%
cis-Entacapone is a metabolite of the catechol-O-methyltransferase (COMT) inhibitor entacapone.
- GC40852N-Demethylerythromycin ACAS: 992-62-1Purity: >95.00%
N-Demethylerythromycin A is a metabolite of erythromycin.
- GC408794-hydroxy Solifenacin N-oxideCAS: 2747991-39-3Purity: >95.00%
4-hydroxy Solifenacin N-oxide is an N-oxide form of 4-hydroxy solifenacin, the major metabolite of solifenacin .
- GC4096821-hydroxy EplerenoneCAS: 334678-67-0Purity: >98.00%
21-hydroxy Eplerenone is a major metabolite of the mineralocorticoid receptor antagonist eplerenone.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC39443 | Solriamfetol hydrochloride | 178429-65-7 | >99.00% | |
Solriamfetol hydrochloride은 도파민과 노르에피네프린 재흡수 억제제이다. Solriamfetol hydrochloride은 시냅스 전 신경세포에 의해 도파민과 노르에피네프린의 재흡수를 차단한다. Solriamfetol hydrochloride은 발작성 수면증이나 수면 무호흡증과 관련된 주간 졸음을 치료하는데 사용된다. | ||||
| GC39611 | 3'-Hydroxy Repaglinide | 874908-14-2 | >98.00% | |
3'-Hydroxy Repaglinide는 Repaglinide의 주요 CYP2C8 대사 산물입니다. | ||||
| GC39757 | Etilevodopa hydrochloride | 39740-30-2 | >98.50% | |
레보도파의 에틸 에스테르 전구약물인 에틸레보도파(L-도파 에틸 에스테르) 염산염은 위장관에서 비특이적 에스테라제에 의해 레보도파와 에탄올로 빠르게 가수분해됩니다. | ||||
| GC39841 | 3,4-Dehydro Cilostazol | 73963-62-9 | >98.00% | |
3,4-Dehydro Cilostazol(OPC-13015)은 Cilostazol의 활성 대사 산물입니다. | ||||
| GC40018 | Donepezil N-oxide | 120013-84-5 | >98.00% | |
Donepezil N-oxide is an active metabolite of the acetylcholinesterase inhibitor donepezil. | ||||
| GC40099 | Leukotriene D4 MaxSpec® Standard | 73836-78-9 | >97.00% | |
류코트리엔 D4 MaxSpec® 표준은 강력한 기관지 수축제입니다. | ||||
| GC40143 | Dihydrotetrabenazine | 3466-75-9 | >98.00% | |
Dihydrotetrabenazine is an active metabolite of the vesicular monoamine transporter 2 (VMAT2) inhibitor tetrabenazine that is generated by hepatic carbonyl reductases. | ||||
| GC40144 | Levofloxacin N-oxide | 117678-38-3 | >95.00% | |
레보플록사신 N-옥사이드는 레보플록사신의 부 대사 산물입니다. | ||||
| GC40145 | (S)-Laudanosine | 2688-77-9 | >98.00% | |
(S)-Laudanosine is the (S) enantiomer of laudanosine, a metabolite of the neuromuscular blocking agents atracurium and cisatracurium. | ||||
| GC40190 | Febuxostat Acyl Glucuronide | 1351692-92-6 | >98.00% | |
Febuxostat acyl glucuronide is a metabolite of the xanthine oxidoreductase inhibitor febuxostat. | ||||
| GC40191 | Ibuprofen Carboxylic Acid | 15935-54-3 | >98.00% | |
Ibuprofen carboxylic acid is a major metabolite of ibuprofen. | ||||
| GC40286 | (E,Z)-2-propyl-2-Pentenoic Acid | 60218-41-9 | >98.00% | |
(E,Z)-2-propyl-2-Pentenoic acid is a bioactive metabolite of valproic acid that exhibits the same profile and potency of anticonvulsant activity in animal models as its parent compound without any observed teratogenicity and hepatotoxicity. | ||||
| GC40298 | N-acetyl-5-Aminosalicylic Acid | 51-59-2 | >98.00% | |
N-acetyl-5-Aminosalicylic acid is a metabolite of the anti-inflammatory agent 5-aminosalicylic acid and its prodrug form, sulfasalazine. | ||||
| GC40300 | Dihydroresveratrol | 58436-28-5 | >98.00% | |
Dihydroresveratrol is a major metabolite of resveratrol that is produced by animal-associated bacteria, including the gut microbiota. | ||||
| GC40301 | Tamoxifen N-oxide | 75504-34-6 | >98.00% | |
Tamoxifen is a selective estrogen receptor modulator that evokes tissue-dependent effects. | ||||
| GC40480 | α-Phenyl-α-(2-pyridyl)acetonitrile | 5005-36-7 | >98.00% | |
α-Phenyl-α-(2-pyridyl)thioacetamide, also known as antigastrin and SC-15396, is an inhibitor of gastric acid secretion. | ||||
| GC40529 | 7-hydroxy Warfarin | 17834-03-6 | >98.00% | |
7-hydroxy Warfarin is a metabolite of (-)-warfarin, which is a more potent vitamin K antagonist than (+)-warfarin. | ||||
| GC40616 | Des-4-fluorobenzyl Mosapride | 152013-26-8 | >96.00% | |
Des-4-fluorobenzyl Mosapride is the primary metabolite of mosapride. | ||||
| GC40627 | tetranor-Misoprostol | - | >95.00% | |
tetranor-Misoprostol is a metabolite of misoprostol. | ||||
| GC40675 | 2-deoxy-Artemisinin | 72826-63-2 | >98.00% | |
2-deoxy-Artemisinin is an inactive metabolite of the antimalarial agent artemisinin. | ||||
| GC40834 | cis-Entacapone | 145195-63-7 | >98.00% | |
cis-Entacapone is a metabolite of the catechol-O-methyltransferase (COMT) inhibitor entacapone. | ||||
| GC40852 | N-Demethylerythromycin A | 992-62-1 | >95.00% | |
N-Demethylerythromycin A is a metabolite of erythromycin. | ||||
| GC40879 | 4-hydroxy Solifenacin N-oxide | 2747991-39-3 | >95.00% | |
4-hydroxy Solifenacin N-oxide is an N-oxide form of 4-hydroxy solifenacin, the major metabolite of solifenacin . | ||||
| GC40968 | 21-hydroxy Eplerenone | 334678-67-0 | >98.00% | |
21-hydroxy Eplerenone is a major metabolite of the mineralocorticoid receptor antagonist eplerenone. | ||||
